Private equity firm Veritas Capital is exploring a sale of Cotiviti Corp that could secure a valuation of over $15 billion for the healthcare analytics company, Bloomberg News reported on Tuesday, citing people with knowledge of the matter.
The firm had earlier been considering an IPO of Cotiviti, but is now weighing a sale due to a bout of volatility in the stock market, the report said.
Veritas declined to comment on the report.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
An official sales process could start as soon as January, the report added.
Cotiviti, which went public in 2016, was acquired by Veritas in 2018 in a take-private deal valued at $4.9 billion, as the PE firm looked to expand its Verscend healthcare IT business.
Source: Reuters
Can’t stop reading? Read more
Quadrivio Group acquires majority stake in Les Secrets de Loly through Made in Italy Fund II
Quadrivio Group acquires majority stake in Les Secrets de Loly through Made in Italy Fund II...
Warburg Pincus explores sale or partnership for Southeast Asian insurer Oona
Warburg Pincus explores sale or partnership for Southeast Asian insurer Oona Warburg Pincus is...
I Squared Capital nears $10bn for flagship infrastructure fund amid sector boom
I Squared Capital nears $10bn for flagship infrastructure fund amid sector boom I Squared Capital...